학술논문
The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas
Document Type
Article
Author
Appenzeller, S.; Thiem, A.; Regensburger, M.; Goebeler, M.-E.; Bargou, R.; Schartl, M.; Goebeler, M.; Meierjohann, S.; Gesierich, A.; Kneitz, H.; Schilling, B.; Siedel, C.; Houben, R.; Schrama, D.; Hufnagel, A.; Jessen, C.; Schmidt, C.; Zirkenbach, V.; Bischler, T.; Gehrig, A.; Rost, S.; Maurus, K.; Rosenwald, A.
Source
In: Cancer . (Cancer, 15 February 2019, 125(4):586-600)
Subject
Language
English
ISSN
10970142
0008543X
0008543X